John C. London, LLB, LLM

Director

50611-London-J.jpg

Mr. London has over 30 years of experience managing a wide variety of public and private businesses and is currently the Chief Executive Officer of Nuvo Pharmaceuticals Inc. Prior to joining Nuvo Pharmaceuticals, Mr. London was Vice Chairman (2005-2009) and then President and Co-CEO (2009-2016) of Nuvo Research Inc. (Nuvo Research) – named changed to Nuvo Pharmaceuticals Inc. March 1, 2016, a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. As an executive management team leader, Mr. London directed Nuvo Research’s growth from a company with no FDA approved products and over $50M of debt to one with 4 FDA approved products, no debt and over $50M of cash.

 

From 2002 to 2005, Mr. London was President and Chief Executive Officer of Powercart Systems Inc., a Canadian-based private company that designs and manufactures battery-equipped workstations that power devices with wireless communication capability.

In 1997, Mr. London co-founded Nighthawk Investments, a private venture capital investment firm. In 1994, Mr. London co-founded Triam Automotive Inc., an international automotive parts manufacturer, where he served as Executive Vice-President. Triam completed its initial public offering in 1994 and was sold to Magna International Inc. in 1998. From 1988 to 1993, he was Executive Vice-President, Secretary and General Counsel at Atoma International, Magna’s interior systems group. Prior to joining Magna, Mr. London was a partner with the Toronto law firm of Strathy, Archibald and Seagram (now Gowlings) where from 1981 to 1988 he practiced corporate law with a focus on banking and insolvency.

Mr. London is a graduate of the University of Western Ontario law school and holds a Masters of Law Degree from University College London.